New Research Trends in Hematology and Cancerous Tumours
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Biomedical Engineering".
Deadline for manuscript submissions: closed (20 December 2021) | Viewed by 9501
Special Issue Editor
Special Issue Information
Dear Colleagues,
Blood/hematologic cancers begin in blood-forming tissues (e.g., bone marrow，lymph system, and blood cells) and were once considered incurable cancers. Thanks to modern-day management, patients with hematologic cancers are seeing remissions and living longer, or even achieving cures. New clinical and scientific findings lead to the advancement in diagnosis and treatment of blood cancers and the development of more efficacious and less toxic therapeutic approaches. We are now at a position where we need to develop these findings into preclinical and clinical outcomes and therefore, we provide a platform for prompt communication of original and innovative research findings associated to blood cancers.
This Special Issue welcomes submissions presented in the form of original, review, and case report articles related to hematologic cancers.
Potential topics include, but are not limited to:
- Leukemia
- Lymphoma
- Myeloma
- Molecular Diagnosis
- Blood Cancer Diagnosis and Staging
Dr. Philipp Bernhard Staber
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Leukemia
- Lymphoma
- Myeloma
- Molecular Diagnosis
- Blood Cancer Diagnosis and Staging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
